See every side of every news story
Published loading...Updated

💉 New drug slows ALS

Summary by Warp News
The drug Tofersen shows good results for patients with ALS caused by mutations in the SOD1 gene, which accounts for 5-6 percent of all ALS cases.Several patients have experienced significant slowing of disease progression, and in some cases the disease has stabilized at the same level.A preventive study called ATLAS is ongoing at Umeå University for healthy individuals who carry SOD1 mutations with a high risk of developing ALS.How Tofersen work…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Warp News broke the news in on Sunday, April 6, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.